Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

23 Jan 2023 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark launches AKYNZEO® I.V. in India – First Fixed I.V. Antiemetic Combination for the Prevention of Chemotherapyinduced Nausea and Vomiting’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..